Navigation Links
ARIUS sale approved by shareholders
Date:9/18/2008

TORONTO, Sept. 18 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that ARIUS Research Inc. shareholders and warrant holders approved the proposed plan of arrangement involving the Company and Roche.

At a special meeting held in Toronto on September 16, 2008, ARIUS shareholders and warrant holders approved the transaction, with 99.99% of Common Shareholders and Class F Warrant holders, voting as a class, and 100% of Class G Warrant holders, represented in person or by proxy, voting in favor of the transaction. The completion of the transaction will result in Common Shareholders receiving $2.44 per Common Share, holders of Class F Warrants receiving $1.44 per Class F Warrant, and holders of Class G Warrants receiving $1.78 per Class G Warrant. The transaction is subject to final Court approval on September 19, 2008, and is expected to close shortly after obtaining Court approval and upon the satisfaction of certain closing conditions.

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusmabs.com

Forward-Looking Statements

Certain statements in this news release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Arius Features Preclinical Data on Antibody Candidates at Two Conferences
2. ARIUS Announces Third Quarter Fiscal 2007 Financial Results
3. Arius highlighted at AACR-NCI-EORTC 2007 International Cancer Conference
4. ARIUS to present at Chinese Global Financial Forum
5. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
6. Arius announces new findings in Trop-2 and CD59 CANCER antibody programs
7. ARIUS to present at BioNorth Biotechnology and Life Sciences Conference
8. ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody
9. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Trigemina, Inc., a biopharmaceutical company focused on the ... products, announced today that the company has appointed Shashidhar ... officer. Dr. Kori brings over 30 years of clinical ... focused in the neuroscience and headache space. ... clinical team given his vast experience managing clinical development ...
(Date:8/4/2015)... ... August 04, 2015 , ... On August 4, 2015, the White House ... entrepreneurs from across the United States to talk about their experiences with innovation and ... chosen to be among the attendees. , One of the day’s aims is to ...
(Date:8/3/2015)... At the 11th hour, London,s ... of Jude Liversage,s campaign so the seven-year-old ...      (Photo: http://photos.prnewswire.com/prnh/20150803/254228 ) ... The Selective Dorsal Rhizotomy (SDR) procedure reduced the spasticity ... wish to kick a ball around like his schoolmates. ...
(Date:8/3/2015)... Medical, Inc. (Nasdaq: AEMD ), the pioneer in ... announced that it will host its First Quarter Fiscal ... 13, 2015 at 4:30 p.m. Eastern Time. ... fiscal 2016 first quarter results.  A recorded version of ... the call at the Investor Relations portion of the ...
Breaking Biology Technology:Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 2Trigemina Appoints Dr. Shashi Kori to the Position of Chief Medical Officer 3White House Invites uBiome CEO Jessica Richman to First-Ever Startup Demo Day 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2
... 12 Eli Lilly and Company (NYSE: LLY ... the 45th Annual Meeting of the American Society of Clinical ... 2, 2009, with the majority of the presentations continuing to ... will present the latest research findings on ALIMTA(R) (pemetrexed for ...
... , - For the ... use CPMRC,s Interdisciplinary Clinical Content Through TSG,s Integrated,Portal Solutions ... and The Shams Group (TSG) have partnered to,provide small- ... integrates with their current health,information systems. , ...
... MSEDMONTON, May 11 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: ... sclerosis (MS), today announced financial and operational results for ... remain on track to obtain the results from MAESTRO-01, ... in patients with secondary progressive multiple sclerosis, in the ...
Cached Biology Technology:Lilly Set to Unveil More Than 50 Studies at ASCO 2009 2Lilly Set to Unveil More Than 50 Studies at ASCO 2009 3Lilly Set to Unveil More Than 50 Studies at ASCO 2009 4Lilly Set to Unveil More Than 50 Studies at ASCO 2009 5Lilly Set to Unveil More Than 50 Studies at ASCO 2009 6CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 2CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 3CPM Resource Center and The Shams Group Partner To Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 4BioMS Medical Announces First quarter 2009 results 2BioMS Medical Announces First quarter 2009 results 3BioMS Medical Announces First quarter 2009 results 4BioMS Medical Announces First quarter 2009 results 5BioMS Medical Announces First quarter 2009 results 6BioMS Medical Announces First quarter 2009 results 7BioMS Medical Announces First quarter 2009 results 8BioMS Medical Announces First quarter 2009 results 9
(Date:7/31/2015)... , 31 de julio de 2015 La ... ) se celebrará por medio de BGI del 22 al 25 ... . Este año, la conferencia celebra su ... se ha convertido en una de las reuniones anuales más ... una de las reuniones más dinámicas, entusiastas y mejores a ...
(Date:7/30/2015)... VIEW, Calif. , July 30, 2015 /PRNewswire/ ... and services for gene function analysis and biomarker ... Guide RNA (sgRNA) Knockout Library targeting all human ... specifically and permanently "knock out" a gene,s function. ... provides a high throughput screening tool so that ...
(Date:7/23/2015)... , July 23, 2015 Research ... addition of the "Global Outlook of the ... offering. The global biometrics market ... public and commercial applications owing to the uptake ... witness a transformation that enhances the growth of ...
Breaking Biology News(10 mins):La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3
... A&M University and University of North Carolina School of ... of diet complexity and estrogen hormone receptors on intestinal ... promoting the growth of certain beneficial intestinal microorganisms can ... determine the effect,of certain factors on intestinal microbiota. ...
... are already used in the displays of smart phones or ... high contrast, but come with a serious drawback: typically, only ... device is actually converted into light. This ratio can be ... or iridium to the active material, but these elements are ...
... An international team of researchers, co-led by scientists at ... produced the first multi-disciplinary evidence for management of cattle ... domestication took place in the Near East, over 10,000 ... achievement in human history. Until now, researchers believed that ...
Cached Biology News:Gut reaction 2Novel LEDs pave the way to cheaper displays 2Researchers uncover origins of cattle farming in China 2
... Spring offers a large collection of ... fetal tissuea, cell lines, and mouse ... in pHD9 vector. The size of ... be from 200bp to 1000bp by ...
... and convenience from the former kit #17295. However, ... problem but also produced some advantages as follows. ... HRP conjugated antibody from lyophilized product to liquid ... of the conjugate has improved so that the ...
Mouse monoclonal [BC-4] to Aggrecan xxPEN ( Abpromise for all tested applications). entrezGeneID: 176 SwissProtID: P16112...
... low melting point agarose where separation is ... for separation of nucleic acids less than ... Micro ABgarose is also suited to capillary ... techniques. At a 3% concentration, Micro ABgarose ...
Biology Products: